Medical was Becton Dickinson’s largest segment in fiscal 2016, bringing in $23.90B of $37.45B (64%).
| Segment | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 |
|---|---|---|---|---|---|---|
| Medical | $12.92B | $13.72B | $19.38B | $23.90B | ||
| Life Sciences | $11.24B | $11.62B | $11.47B | $11.49B | ||
| Diagnostics | — | — | — | — | ||
| Biosciences | — | — | — | — | ||
| Interventional | — | — | — | $2.07B | ||
| Total | $24.16B | $25.34B | $30.85B | $37.45B |
Becton Dickinson brought in $37.45B from its three segments in fiscal 2016, the year ended September 30, 2016. Becton Dickinson regrouped these segments after fiscal 2015, so the total does not compare directly with that year's $30.85B. Medical was the largest at $23.90B (63.8%), ahead of Life Sciences at $11.49B (30.7%) and Interventional at $2.07B (5.5%).
Compared with fiscal 2015, Medical grew 23.3% to $23.90B and Life Sciences grew 0.2% to $11.49B.
Becton Dickinson began breaking out Interventional in fiscal 2016, when it brought in $2.07B.
United States was Becton Dickinson’s largest region in fiscal 2017, bringing in $19.51B of $36.28B (54%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| United States | $10.25B | $15.21B | $20.68B | $19.51B | |||||
| Revenues | — | — | — | — | |||||
| Europe | $7.15B | $7.30B | $8.02B | $7.76B | |||||
| Greater Asia | $4.31B | $4.64B | $5.08B | $5.23B | |||||
| Other | $3.63B | $3.70B | $3.68B | $3.77B | |||||
| Others | — | — | — | — | |||||
| Segment Geographical Groups Of Countries Group Four | — | — | — | — | |||||
| Asia Pacific | — | — | — | — | |||||
| Segment Geographical Groups Of Countries Group Three | — | — | — | — | |||||
| Total | $25.34B | $30.85B | $37.45B | $36.28B |
Becton Dickinson brought in $36.28B from its four regions in fiscal 2017, the year ended September 30, 2017. That was down 3.1% from $37.45B in fiscal 2016. United States was the largest at $19.51B (53.8%), ahead of Europe at $7.76B (21.4%) and Greater Asia at $5.23B (14.4%). The remaining region, Other, brought in $3.77B.
Compared with fiscal 2016, Greater Asia grew fastest, up 3.1% to $5.23B, while United States fell the most, down 5.6% to $19.51B. From fiscal 2014 to 2017, combined revenue from these regions grew from $25.34B to $36.28B, a compound annual growth rate of 12.7%. United States' share of the total rose from 40.5% to 53.8%.
Becton Dickinson (BDX) reports its revenue by segment and by geography. In fiscal 2016, Medical was its largest segment, bringing in $23.90B (63.8% of the total), followed by Life Sciences at $11.49B (30.7%).
Medical was Becton Dickinson's largest segment in fiscal 2016, bringing in $23.90B, or 63.8% of the $37.45B total across its three segments.
United States was Becton Dickinson's largest region in fiscal 2017, bringing in $19.51B, or 53.8% of the $36.28B total across its four regions.
Among Becton Dickinson's regions that make up at least 2% of revenue, Greater Asia grew fastest in fiscal 2017, up 3.1% from $5.08B to $5.23B.
Every figure comes from Becton Dickinson's annual financial filings, as reported. Each line keeps the name Becton Dickinson gives it, and years follow its fiscal calendar.
Becton Dickinson's revenue by segment goes back to fiscal 2011, with figures through fiscal 2016. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.